NCT05629195 (PICC) is a NA clinical trial of tunneled PICC in Complications; Catheter, sponsored by First People's Hospital of Foshan.

Who is sponsoring NCT05629195?

NCT05629195 is sponsored by First People's Hospital of Foshan.

What drugs are being tested in NCT05629195?

Interventions in NCT05629195: tunneled PICC.

What condition does NCT05629195 study?

NCT05629195 studies Complications; Catheter.

Is NCT05629195 still recruiting?

NCT05629195 is currently status unknown. Last updated 29 November 2022.

Last reviewed 2022-11-29 · How we verify

NCT05629195: PICC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Skin Laxity on the PICC

Status unknown NA Last updated 29 November 2022

What this trial tests

NA trial testing tunneled PICC in Complications; Catheter in 356 participants. Status unknown.

Timeline

1 December 2022

Primary endpoint
1 September 2023

30 December 2023

Quick facts

Lead sponsor	First People's Hospital of Foshan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	356
Start date	1 December 2022
Primary completion	1 September 2023
Estimated completion	30 December 2023

Drugs / interventions tested

tunneled PICC

Conditions studied

Complications; Catheter — all drugs for Complications; Catheter →

Sponsor

First People's Hospital of Foshan

Who can join

18 and older, any sex, with Complications; Catheter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the clinical effect of tunneled PICC by comparing the rate of complications of the two groups of patients (tunneled PICC vs conventional PICC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of tunneled PICC

Trials testing the same drug.

NCT05870449 — The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications · NA · unknown

Other First People's Hospital of Foshan trials

Trials by the same sponsor.

NCT07425145 — Transcutaneous Electrical Acustimulation for IBS-D: A Multicenter Study · NA · not yet recruiting
NCT07525804 — Flipped-Discharge Education for PTCD-Managed Malignant Obstructive Jaundice · NA · completed
NCT04446663 — Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma · Phase 2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05629195 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First People's Hospital of Foshan
Last refreshed: 29 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05629195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing